Psychiatry and Neurology, Neurology · Lawrence, MA
NPI
1982691655
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
354 Merrimack St
Lawrence, MA, 01843
Phone (978) 687-2321
Groups this clinician bills Medicare through
Medicare paid, 2024
$175K
1,969 services
Medicare patients, 2024
515
Average age 67
Drug cost, 2024
$1.7M
4,622 prescriptions
Company payments, 2025
$32K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vladan P Milosavljevic was code 99213 (office e&m - established), 561 times for 296 patients. In total Vladan P Milosavljevic billed 1,969 services in 26 codes, and Medicare paid $175K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 561 | 296 | $68.47 | $38K |
| 99214 Office E&M - Established | Office | 407 | 250 | $95.73 | $39K |
| 95886 Electrical Nerve Conductivity | Office | 243 | 118 | $78.78 | $19K |
| 99204 Office E&M - New | Office | 143 | 143 | $129.92 | $19K |
| 95911 Electrical Nerve Conductivity | Office | 83 | 78 | $173.96 | $14K |
| 99442 Telephone Services | Office | 66 | 45 | $70.15 | $4,630 |
| 95816 Neurologic | Office | 59 | 59 | $325.55 | $19K |
| 95913 Electrical Nerve Conductivity | Office | 40 | 39 | $221.04 | $8,842 |
| 95885 Electrical Nerve Conductivity | Office | 31 | 31 | $50.79 | $1,575 |
| 95910 Electrical Nerve Conductivity | Office | 23 | 22 | $139.56 | $3,210 |
| 99441 Telephone Services | Office | 16 | 15 | $43.63 | $698 |
| 99205 Office E&M - New | Office | 15 | 15 | $171.10 | $2,566 |
By year: 2022 $201K for 2,172 services; 2023 $184K for 1,815 services; 2024 $175K for 1,969 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vladan P Milosavljevic prescribed most often to Medicare patients was Levetiracetam, with 478 prescriptions and refills. In total Vladan P Milosavljevic wrote 4,622 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 478 | 680 | 69 | $13K |
| Gabapentin Generic | 430 | 492 | 83 | $6,451 |
| Donepezil Hcl Generic | 313 | 549 | 84 | $2,741 |
| Lamotrigine Generic | 214 | 296 | 32 | $3,996 |
| Topiramate Generic | 189 | 313 | 32 | $2,202 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 174 | 277 | 37 | $2,335 |
| Divalproex Sodium Generic | 161 | 198 | 16 | $7,197 |
| Memantine Hcl Er Memantine Hcl | 152 | 188 | 26 | $7,283 |
| Primidone Generic | 131 | 221 | 20 | $2,980 |
| Phenytoin Sodium Extended Generic | 128 | 160 | 15 | $3,352 |
| Phenobarbital Generic | 125 | 133 | 11 | $1,924 |
| Dilantin Phenytoin Sodium Extended | 108 | 159 | 12 | $19K |
| Lacosamide Generic | 96 | 104 | 11 | $9,249 |
| Divalproex Sodium Er Divalproex Sodium | 91 | 143 | 14 | $5,517 |
| Carbamazepine Er Carbamazepine | 91 | 113 | 11 | $9,280 |
Brand drugs: 538 claims; generic drugs: 3,959 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vladan P Milosavljevic $32K ($32K in general payments such as food, travel and fees) from 16 companies. The largest payer was Supernus Pharmaceuticals, Inc. with $24K.
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. SUPN | 58 | $24K |
| Abbvie Inc. ABBV | 15 | $6,692 |
| LivaNova USA, Inc. LIVN | 14 | $390 |
| Merz Pharmaceuticals, LLC | 7 | $290 |
| Teva Pharmaceuticals USA, Inc. TEVA | 13 | $155 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $141 |
| Lilly USA, LLC LLY | 5 | $135 |
| Biogen, Inc. BIIB | 6 | $112 |
| ANI Pharmaceuticals, Inc. ANIP | 4 | $105 |
| Collegium Pharmaceutical, Inc. COLL | 5 | $87.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.